Editorial: Covid-19 and obesity.
作者信息
Guglielmi Valeria, El Ghoch Marwan, Bettini Silvia, Holly Jeff M P
机构信息
Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Internal Medicine Unit - Obesity Center, University Hospital Policlinico Tor Vergata, Rome, Italy.
出版信息
Front Endocrinol (Lausanne). 2022 Dec 23;13:1122274. doi: 10.3389/fendo.2022.1122274. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Covid-19 and obesity.社论：新冠病毒-19与肥胖症
Front Endocrinol (Lausanne). 2022 Dec 23;13:1122274. doi: 10.3389/fendo.2022.1122274. eCollection 2022.
2
Evaluating Possible Mechanisms Linking Obesity to COVID-19: a Narrative Review.评估肥胖与 COVID-19 之间关联的可能机制：一项叙述性综述。
Obes Surg. 2022 May;32(5):1689-1700. doi: 10.1007/s11695-022-05933-0. Epub 2022 Feb 3.
3
Obesity as an adipose tissue dysfunction disease and a risk factor for infections - Covid-19 as a case study.肥胖作为一种脂肪组织功能障碍疾病和感染的危险因素——以新冠病毒感染为例。
Eur J Intern Med. 2021 Sep;91:3-9. doi: 10.1016/j.ejim.2021.03.031. Epub 2021 Apr 2.
4
COVID-19 and Obesity: Overlapping of Two Pandemics.新型冠状病毒肺炎和肥胖症：两种大流行病的叠加。
Obes Facts. 2021;14(6):579-585. doi: 10.1159/000518386. Epub 2021 Sep 24.
5
The majority of SARS-CoV-2-specific antibodies in COVID-19 patients with obesity are autoimmune and not neutralizing.在肥胖的 COVID-19 患者中，大多数 SARS-CoV-2 特异性抗体是自身免疫性的，而不是中和性的。
Int J Obes (Lond). 2022 Feb;46(2):427-432. doi: 10.1038/s41366-021-01016-9. Epub 2021 Nov 7.
6
Correspondence on "Obesity after the Covid-19 pandemic".
J Pediatr Endocrinol Metab. 2022 Mar 2;35(4):529. doi: 10.1515/jpem-2022-0073. Print 2022 Apr 26.
7
Double trouble: a pandemic of obesity and COVID-19.双重麻烦：肥胖症与新冠疫情大流行
Lancet Gastroenterol Hepatol. 2021 Aug;6(8):608. doi: 10.1016/S2468-1253(21)00190-4.
8
Obesity and Risk of COVID-19 Infection and Severity: Available Evidence and Mechanisms.肥胖与 COVID-19 感染和严重程度的关系：现有证据和机制。
Adv Exp Med Biol. 2021;1321:97-107. doi: 10.1007/978-3-030-59261-5_8.
9
Obesity and COVID-19 in children and adolescents: a double pandemic.儿童和青少年肥胖与 COVID-19：双重大流行。
Acta Biomed. 2022 Jun 6;93(S3):e2022195. doi: 10.23750/abm.v93iS3.13075.
10
Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic.2019冠状病毒病大流行期间肥胖2型糖尿病患者的药物治疗管理
Obes Surg. 2021 Jan;31(1):413-414. doi: 10.1007/s11695-020-04799-4.
引用本文的文献
1
Risk factors for severe outcomes of coronavirus disease 2019 through the waves of the pandemic: Comparing patients with and without solid organ transplantation.通过疫情的波次比较合并和未合并实体器官移植的 COVID-19 患者严重结局的危险因素。
Transpl Infect Dis. 2024 Oct;26(5):e14333. doi: 10.1111/tid.14333. Epub 2024 Jul 9.
2
COVID-19 Vaccination Strategies in the Endemic Period: Lessons from Influenza.流行期的新冠病毒疫苗接种策略：来自流感的经验教训
Vaccines (Basel). 2024 May 9;12(5):514. doi: 10.3390/vaccines12050514.
本文引用的文献
1
Bariatric surgery for metabolic unhealthy obesity (MUO) during the COVID era: short-term results of a high-volume center.肥胖代谢综合征（MUO）患者的减重代谢手术：大中心的短期疗效。
Eat Weight Disord. 2022 Dec;27(8):3119-3124. doi: 10.1007/s40519-022-01438-y. Epub 2022 Jul 19.
2
Inflammation, underweight, malignancy and a marked catabolic state as predictors for worse outcomes in COVID-19 patients with moderate-to-severe disease admitted to Internal Medicine Unit.炎症、体重过轻、恶性肿瘤和明显的分解代谢状态是导致中重度 COVID-19 患者入住内科单元后预后较差的预测因素。
PLoS One. 2022 May 18;17(5):e0268432. doi: 10.1371/journal.pone.0268432. eCollection 2022.
3
Low-grade inflammation, CoVID-19, and obesity: clinical aspect and molecular insights in childhood and adulthood.低度炎症、COVID-19 和肥胖：儿童和成人的临床方面和分子见解。
Int J Obes (Lond). 2022 Jul;46(7):1254-1261. doi: 10.1038/s41366-022-01111-5. Epub 2022 Apr 7.
4
Visceral fat inflammation and fat embolism are associated with lung's lipidic hyaline membranes in subjects with COVID-19.COVID-19 患者的内脏脂肪炎症和脂肪栓塞与肺部的脂肪性透明膜有关。
Int J Obes (Lond). 2022 May;46(5):1009-1017. doi: 10.1038/s41366-022-01071-w. Epub 2022 Jan 26.
5
Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study.在英格兰 690 万人中，体重指数与 COVID-19 严重程度的关联：一项前瞻性、基于社区的队列研究。
Lancet Diabetes Endocrinol. 2021 Jun;9(6):350-359. doi: 10.1016/S2213-8587(21)00089-9. Epub 2021 Apr 28.
6
A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19.对新型冠状病毒肺炎患者合并症的地理差异以及相关严重程度和死亡率的系统评价与荟萃分析。
Sci Rep. 2021 Apr 20;11(1):8562. doi: 10.1038/s41598-021-88130-w.
7
Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role?肥胖与病毒感染易感性及严重程度：从流感到 COVID-19 的启示。瘦素是否发挥作用？
Int J Mol Sci. 2021 Mar 20;22(6):3183. doi: 10.3390/ijms22063183.
8
Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships.肥胖与 COVID-19 患者：流行病学和生物学关系的全球视角。
Obes Rev. 2020 Nov;21(11):e13128. doi: 10.1111/obr.13128. Epub 2020 Aug 26.
9
Obesity and impaired metabolic health in patients with COVID-19.COVID-19 患者的肥胖和代谢健康受损。
Nat Rev Endocrinol. 2020 Jul;16(7):341-342. doi: 10.1038/s41574-020-0364-6.
Zotero 插件